Novel Method Introduced for Dry Storage of Biological Samples
By LabMedica International staff writers Posted on 12 Mar 2018 |

Image: An illustration of the novel method for transporting biospecimens, which eliminates the current method using cold-chain transport (Photo courtesy of Washington University).
A novel method for preserving biological samples collected for diagnostic testing at room temperature may one day eliminate the need for refrigeration, which is often not available in third-world settings.
Investigators at Washington University (St. Louis, MO, USA) have introduced a universal biospecimen preservation approach based on nanoporous material encapsulation for preserving protein biomarkers in biofluids under normal (nonrefrigerated) storage conditions. The protein biomarkers in the relevant biofluids such as blood, urine, serum, and plasma are first encapsulated within nanoporous zeolitic imidazolate framework-8 (ZIF-8) crystals and then dried on paper substrates via a dry spot sample collection method. Zeolitic imidazolate frameworks (ZIFs) are a class of metal-organic frameworks composed of tetrahedrally coordinated transition metal ions (e.g. Fe, Co, Cu, Zn) connected by imidazolate linkers.
To test the dry storage method, the investigators used artificial urine samples spiked with neutrophil gelatinase-associated lipcalin (NGAL), a biomarker for acute kidney injury; and blood samples spiked with CA-125, a biomarker for ovarian cancer. The samples were mixed with precursors of the nanoporous material ZIF-8 and then dried on paper at room temperature.
Results revealed that urine samples stored dry at room temperature retained more than 90% of NGAL. Control samples without ZIF-8 encapsulation had less than 30% of NGAL preserved. Blood samples spiked with CA-125 and encapsulated by ZIF-8 showed about 85% preservation, while those without the encapsulation showed 50% or less preservation. Overall, results obtained with samples stored dry at temperatures up to 40 degrees Celsius showed preservation efficacy comparable to those maintained by the refrigeration method (freezing liquid samples at −20 degrees Celsius).
"One of our next steps is to take the technology out of the laboratory and commercialize it so that it can work to the greatest good for the greatest number of people," said contributing author Dr. Evan D. Kharasch, professor of biochemistry and molecular biophysics at Washington University. "This would make it widely available in both first-world countries as well as emerging countries and in emergency situations or environmental disasters where we need to deploy people and have scarce resources."
The dry storage protocol was described in detail in the February 1, 2018, online edition of the journal Chemistry of Materials.
Related Links:
Washington University
Investigators at Washington University (St. Louis, MO, USA) have introduced a universal biospecimen preservation approach based on nanoporous material encapsulation for preserving protein biomarkers in biofluids under normal (nonrefrigerated) storage conditions. The protein biomarkers in the relevant biofluids such as blood, urine, serum, and plasma are first encapsulated within nanoporous zeolitic imidazolate framework-8 (ZIF-8) crystals and then dried on paper substrates via a dry spot sample collection method. Zeolitic imidazolate frameworks (ZIFs) are a class of metal-organic frameworks composed of tetrahedrally coordinated transition metal ions (e.g. Fe, Co, Cu, Zn) connected by imidazolate linkers.
To test the dry storage method, the investigators used artificial urine samples spiked with neutrophil gelatinase-associated lipcalin (NGAL), a biomarker for acute kidney injury; and blood samples spiked with CA-125, a biomarker for ovarian cancer. The samples were mixed with precursors of the nanoporous material ZIF-8 and then dried on paper at room temperature.
Results revealed that urine samples stored dry at room temperature retained more than 90% of NGAL. Control samples without ZIF-8 encapsulation had less than 30% of NGAL preserved. Blood samples spiked with CA-125 and encapsulated by ZIF-8 showed about 85% preservation, while those without the encapsulation showed 50% or less preservation. Overall, results obtained with samples stored dry at temperatures up to 40 degrees Celsius showed preservation efficacy comparable to those maintained by the refrigeration method (freezing liquid samples at −20 degrees Celsius).
"One of our next steps is to take the technology out of the laboratory and commercialize it so that it can work to the greatest good for the greatest number of people," said contributing author Dr. Evan D. Kharasch, professor of biochemistry and molecular biophysics at Washington University. "This would make it widely available in both first-world countries as well as emerging countries and in emergency situations or environmental disasters where we need to deploy people and have scarce resources."
The dry storage protocol was described in detail in the February 1, 2018, online edition of the journal Chemistry of Materials.
Related Links:
Washington University
Latest Molecular Diagnostics News
- Blood Test Could Predict Relapse of Autoimmune Blood Vessel Disease
- First-of-its-Kind Blood Test Detects Trauma-Related Diseases
- Key Gene Identified in Common Heart Disease Unlocks Life-Saving Diagnostic Potential
- Cheap Cell-Free DNA Based Test Accurately Predicts Preterm Birth
- RNA Blood Test Detects Cancers and Resistance to Treatment
- IL-6 Outperforms Traditional Tests for Early Sepsis Detection
- Simple Blood Test Improves Heart Attack and Stroke Risk Prediction
- Blood Biomarker Test Could Detect Genetic Predisposition to Alzheimer’s
- Novel Autoantibody Against DAGLA Discovered in Cerebellitis
- Blood Test Could Identify Patients at Risk for Severe Scleroderma
- Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer
- Rapid Blood Test Identifies Pre-Symptomatic Patients with Parkinson’s Disease
- Blood Test for Early Alzheimer's Detection Achieves Over 90% Accuracy
- RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
- First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
- Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more